Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7879 | 0.98 | — | — | |
| SCHEMBL28947049 | 0.98 | — | — | |
| Ethylenediamine SCHEMBL10527046 | 0.96 | — | — | |
| Carbimide SCHEMBL2230181 | 0.94 | — | — | |
| Iodomethane SCHEMBL6702889 | 0.94 | — | — | |
| Carbimide SCHEMBL2231110 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL9011753 | 0.83 | — | — | |
| SCHEMBL6446030 | 0.80 | CYP1A2 (0.30) | — | |
| Dicyclohexylcarbodiimide SCHEMBL10919461 | 0.79 | EPHX1 (0.43) | — | |
| Hydrochloric Acid SCHEMBL28375754 | 0.79 | CYP1A2 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2745 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118286866-A | High-selectivity high-flux ultrafiltration membrane and preparation method thereof | 上海乐纯生物技术股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118184581-A | Synthesis and application of Delta opioid receptor biased agonist compound and analgesic drug | 中国科学院大连化学物理研究所 | 2024-06-14 | — | — | CN | claimed |
| CN-118073591-A | Preparation method of NGPs-3DGO enzyme type fuel cell | 池州学院 | 2024-05-24 | — | — | CN | claimed |
| CN-117398482-A | Ovalbumin loaded nitro-radical oxynitride nanocomposite and preparation method and application thereof | 浙江理工大学 | 2024-01-16 | — | — | CN | claimed |
| WO-2024003737-A1 | PROCESS AND INTERMEDIATES USEFUL FOR PREPARING NIRMATRELVIR | PFIZER INC. (US) | 2024-01-04 | — | — | WO | claimed |
| CN-116585267-A | Pickering emulsion stabilized by self-assembled nanofiber and preparation method thereof | 华南理工大学 | 2023-08-15 | — | — | CN | claimed |
| US-20230241209-A1 | METHOD FOR PREPARING COMBINATION VACCINE ADJUANT BASED ON CARBOXYL MODIFIED ALUMINUM OXYHYDROXIDE NANOPARTICLES | DALIAN UNIVERSITY OF TECHNOLOGY (CN) | 2023-08-03 | — | — | US | claimed |
| CN-116355044-A | Amide compound, preparation method and application thereof | 中国科学院上海药物研究所 | 2023-06-30 | — | — | CN | claimed |
| CN-114917777-B | Preparation method of firm and organic solvent-resistant cation exchange membrane | 浙江浙能技术研究院有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-115887378-A | Targeted reduction sensitive polymer micelle, preparation method and application | 陕西科技大学 | 2023-04-04 | — | — | CN | claimed |
| EP-1534675-A1 | FLUORO AND SULPHONYLAMINO CONTAINING 3,6-DISUBSTITUTED AZABICYCLO[3.1.0]HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES, LTD. (IN) | 2005-06-01 | — | — | EP | claimed |
| CN-1538006-A | Biopaper | 张 清 | 2004-10-20 | — | — | CN | claimed |
| EP-1466920-A1 | Process for the preparation of steroidal 17 beta-carbothioates | Alpharma APS (DK) | 2004-10-13 | — | — | EP | claimed |
| WO-2004018422-A1 | FLUORO AND SULPHONYLAMINO CONTAINING 3,6-DISUBSTITUTED AZABICYCLO (3.1.0) HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2004-03-04 | — | — | WO | claimed |
| US-6649778-B1 | Reacting taxane with blocked amino acid to form intermediate, deprotecting with about equimolar amount of secondary amine to prepare 2'-substituted taxane | ENZON, INC. | 2003-11-18 | — | — | US | claimed |
| US-6646120-B1 | Polysaccharides with side chains of methylcarboxylate, carboxymethylbenzylamide, sulfate and sulfonate groups; use as anti-thrombotic, substitute for plasma and modulator of cell proliferation | BIODEX (FR) | 2003-11-11 | — | — | US | claimed |
| EP-1191024-A1 | Thiadiazines and their use as inhibitors of metalloproteinases | Tschesche, Harald (DE) | 2002-03-27 | — | — | EP | claimed |
| CN-1041419-C | Mitomycin C-dextran and its preparing method | QI CHUNLIAN (CN) | 1998-12-30 | — | — | CN | claimed |
| US-5584875-A | DETERMINING CARRYING VOLUME OF POROUS TEXTILE TUBE SUBSTRATE, LOADING WITH VOLUME OF GELABLE MATERIAL SOLUTION TO FILL INTERSTICES, CROSSLINKING GELABLE MATERIAL IN INTERSTICES AND ON SURFACE OF SUBSTRATE | C. R. BARD, INC. (US) | 1996-12-17 | — | — | US | claimed |
| US-5391819-A | Process of making chiral 2-aryl-1,4-butanediamine derivatives as useful neurokinin-A antagonists | MERCK & CO., INC. (US) | 1995-02-21 | — | — | US | claimed |